Increased expression of HERV-K (HML-2) and its constituent proteins has been observed in hepatocellular carcinoma (HCC) and glioblastoma (GBM), and in HCC they have been found to be negative prognostic indicators [82,135]. Here, CLEC10A is linked to glioblastoma.